HydroCision

HydroCision’s FluidJet-based devices—including TenJet and SpineJet—are commercially available. Clinical results highlight improved precision in soft tissue removal with less collateral damage compared to traditional methods. The TenJet device enables targeted removal of degenerative tendon tissue under ultrasound guidance with rapid rehabilitation; SpineJet products are used for minimally invasive discectomy procedures.

No large-scale pivotal trial data or recent clinical trial outcomes were found in public sources; however, the company has completed at least one prospective controlled randomized trial for microdiscectomy as of its last major funding round.